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Abstract
Purpose The development of metabolic diseases such as type 2 diabetes (T2D) is closely linked to a complex interplay 
between genetic and dietary factors. The prevalence of abdominal obesity, hyperinsulinemia, dyslipidaemia, and high blood 
pressure among Brazilian adolescents is increasing and hence, early lifestyle interventions targeting these factors might be 
an effective strategy to prevent or slow the progression of T2D.
Methods We aimed to assess the interaction between dietary and genetic factors on metabolic disease-related traits in 200 
healthy Brazilian young adults. Dietary intake was assessed using 3-day food records. Ten metabolic disease-related single 
nucleotide polymorphisms (SNPs) were used to construct a metabolic-genetic risk score (metabolic-GRS).
Results We found significant interactions between the metabolic-GRS and total fat intake on fasting insulin level 
 (Pinteraction = 0.017), insulin-glucose ratio  (Pinteraction = 0.010) and HOMA-B  (Pinteraction = 0.002), respectively, in addition to a 
borderline GRS-fat intake interaction on HOMA-IR  (Pinteraction = 0.051). Within the high-fat intake category [37.98 ± 3.39% 
of total energy intake (TEI)], individuals with ≥ 5 risk alleles had increased fasting insulin level (P = 0.021), insulin-glucose 
ratio (P = 0.010), HOMA-B (P = 0.001) and HOMA-IR (P = 0.053) than those with < 5 risk alleles.
Conclusion Our study has demonstrated a novel GRS-fat intake interaction in young Brazilian adults, where individuals 
with higher genetic risk and fat intake had increased glucose and insulin-related traits than those with lower genetic risk. 
Large intervention and follow-up studies with an objective assessment of dietary factors are needed to confirm our findings.
Keywords Genetic risk score · Metabolic traits · Brazil · Fat intake · Gene–diet interaction
Introduction
Metabolic diseases, such as type 2 diabetes (T2D), have been 
recognised as a significant public health problem worldwide 
[1, 2], playing a critical role in medical impoverishment 
[3–6]. T2D is a major contributor to morbidity and mor-
tality and individuals with T2D have a five-fold increased 
risk of developing cardiovascular diseases (CVD) [7]. The 
prevalence of diabetes has increased globally (over 463 mil-
lion adults) [8] but at a faster rate in low- and middle-income 
countries (LMICs) [9]. In Brazil, the prevalence of T2D has 
increased by 24% between 2006 and 2019 [10] and an esti-
mate of 65,581 deaths have been shown to be caused by 
diabetes among adults aged 35–80 years [11]. It has been 
reported that the prevalence of prediabetes and T2D among 
Brazilian adolescents were 22.0% and 3.3%, respectively 
[12]. Studies have also demonstrated the occurrence of car-
diometabolic risk factors including abdominal obesity, high 
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insulin levels, dyslipidaemia, and high blood pressure among 
Brazilian adolescents [12–14]. Hence, early interventions 
targeting these factors might be an effective strategy to pre-
vent or slow the progression of T2D and decrease the risk of 
CVD and associated premature mortality [8].
Much of the increase in the prevalence of metabolic dis-
eases in Brazil is attributed to an epidemiological transition 
characterised by changes in Brazilian age structure, popu-
lation ageing, reduced rates of infant mortality and fertil-
ity and increased low birth weight [15–19]. Changes in the 
cultural and socioeconomic patterns, for instance, increas-
ing urbanisation and economic improvement, have led to 
negative changes in lifestyle behaviours, including physical 
inactivity and unhealthy diet, in the Brazilian adolescent/ 
young adult population [20]. A previous study has shown 
that the intake of saturated fatty acids (SFA) was higher in 
adolescents than adults in Brazil [21]. Animal and human 
studies have demonstrated an association between increased 
dietary fat intake and increased insulin resistance [22–24]. 
In addition, the dietary behaviours of Brazilian young adults 
have been shown to be characterised by higher intakes of 
unhealthy foods than middle-aged and older adults, high-
lighting the need for age-specific public health interventions 
[25].
The development of metabolic diseases such as T2D is 
closely linked to a complex interplay between genetic and 
lifestyle factors, such as diet. Numerous genetic loci have 
been shown to be associated with T2D [26–29] and related 
traits [30, 31] and, to date, 243 genetic loci have been identi-
fied to be associated with the risk of T2D in multiple ethnic 
groups [26–29]. Single nucleotide polymorphisms (SNPs) 
have only a modest effect on disease risk, thus, generating a 
genetic risk score (GRS) combining several SNPs across the 
genome is necessary for increasing power to identify disease 
predisposition patterns of an individual [32]. Evidence has 
suggested that the genetic risk of metabolic diseases can be 
modified by dietary intake [33–37]. There are a few gene-
diet interaction studies in Brazilians; however, the studies 
have focused only on cardiovascular disease related traits 
[38–40]. To date, there are no GRS-diet interaction stud-
ies on metabolic traits in Brazilians. Hence, we aimed to 
investigate the interaction of 10 metabolic disease-related 
SNPs, as a GRS, with dietary intake on metabolic traits in 
200 healthy Brazilian young adults.
Methodology
Study population
Obesity, Lifestyle and Diabetes in Brazil (BOLD) is a cross-
sectional study of Brazilian healthy young adults aged 
19–24 years recruited at the Federal University of Goiás 
(UFG) between March and June 2019. This study was con-
ducted as part of the ongoing GeNuIne (gene-nutrient inter-
actions) Collaboration, which aims to investigate the impact 
of genes and lifestyle factors on chronic diseases using 
data from multiple ethnic groups [41, 42]. All participants 
completed baseline questionnaires regarding health status, 
demographics, and socioeconomic status. The study exclu-
sion criteria included those who are 1) using lipid-lowering 
or hypoglycemic drugs and mineral or vitamin supplements, 
2) undergoing dietary interventions in the last 6 months, 3) 
having acute clinical conditions such as infection, inflam-
mation, fever or diarrhoea, or confirmed diagnosis of 
chronic diseases such as diabetes mellitus, moderate/severe 
hypertension, cancer, rheumatoid arthritis and cardiovascu-
lar complications, 4) doing vigorous physical activity. In 
total, 416 individuals showed interest in participating in the 
study. However, 207 participants met the inclusion criteria 
and only 200 completed the study (Fig. 1). Out of the 200 
participants, only 194 had information on genetic and pheno-
typic measurements as DNA samples were not available for 
6 participants. The study was approved by the Ethics Com-
mittee of the Federal University of Goiás (protocol number 
3.007.456, 08/11/2018), and performed according to the 
ethical principles in the Declaration of Helsinki. All partici-
pants gave written informed consent for study participation.
Anthropometric and biochemical measurements
Body weight, height and waist circumference (WC) were 
measured using standardized methods. The weighing was 
performed on a Tanita® portable electronic scale, with a 
maximum capacity of 150 kg. For height, a stadiometer with 
a movable rod was used. WC was measured using an inelas-
tic measuring tape. Body mass index (BMI) was calculated 
as weight in kilograms divided by height in  meters2 and WC 
measurement was taken using a non-extensible measuring 
tape with partici-pants in light clothing [43]. Body composi-
tion was performed by Dual Energy Radiological Absorp-
tiometry (DXA), using the Lunar DPX NT model (General 
Electric Medical Systems Lunar®; Madison, USA).
Blood samples were collected by peripheral venous 
puncture in the morning after a 12-h fast and the volun-
teers were advised not to consume alcohol 72 h before 
the blood collection. Samples were immediately pro-
cessed after the collection at the Romulo Rocha Labora-
tory (Goiânia, Brazil). Fasting serum glucose and insulin 
were collected in BD Vacutainer® tube and determined 
by the enzymatic colorimetric method, with an automatic 
System Vitros Chemistry 950 XRL (Johnson & Johnson, 
New Brunswick, NJ, USA). Plasma glycated haemoglo-
bin (HbA1c) was collected in an ethylene-diamine-tetra-
acetic acid (EDTA) tubes BD Vacutainer® and measured 
using high-pressure chromatography (HPLC-Bio-Rad 
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Laboratories, Hercules, CA, USA). Plasma samples were 
obtained by centrifugation at 3500 rpm for ten minutes 
at 4  °C. The homeostasis model assessment (HOMA) 
was used to assess the degree of insulin resistance (IR) 
(HOMA-IR) and β-cell function (HOMA-B). HOMA-IR 
and HOMA-B were calculated as follows: [fasting insulin 
levels (mU/l) × fasting glucose levels (mmol/l)/22.5] and 
[20 × fasting insulin levels)/(fasting glucose levels − 3.5], 
respectively [44].
Dietary assessment
Food intake was assessed by trained nutritionists using non-
consecutive 3-day food records, including a weekend day 
[45]. Individuals were provided with measuring cups and 
spoons of different sizes to assist them in estimating portion 
size for each food. Foods consumed were converted into 
grams using the Avanutri Online® diet calculation software 
(Avanutri Informática Ltda, Rio de Janeiro, Brazil).
Genotyping
The blood samples (3 ml each) were collected in an EDTA 
tubes BD Vacutainer® tubes and transported at a controlled 
temperature (- 80ºC) by the World Courier Company to per-
form genotyping at LGC Genomics (http:// www. lgcgr oup. 
com/ servi ces/ genot yping), employing the competitive allele-
specific PCR-KASP® assay.
SNP selection and GRS calculation
We selected 12 SNPs that have shown associations with 
metabolic traits in multiple ethnic groups [26–31]. The 
detailed information of these SNPs is shown in Table S1. 
Two SNPs were excluded from the current analysis, as 
the Calpain 10 (CAPN10) rs2975760 SNP was not in 
Hardy–Weinberg equilibrium (HWE) and the melanocor-
tin 4 Receptor (MC4R) rs2229616 SNP had a minor allele 
frequency (MAF) of less than 1%. Unweighted metabolic-
GRS was calculated by summing the number of risk alleles 
Fig. 1  Flow chart showing the participant recruitment process in the 
BOLD study. In total, 416 individuals were initially screened. After 
excluding participants based on the exclusion criteria, 207 were 
included in the study. However, only 200 completed the study. BMI 
body mass index, WC waist circumference, HbA1c glycated haemo-
globin A1c, HOMA-IR homeostasis model assessment estimate of 
insulin resistance, HOMA-B homeostasis model assessment estimate 
of insulin secretion, TCF7L2 Transcription factor 7-like 2, MC4R 
melanocortin 4 Receptor, PPARG Peroxisome proliferator-activated 
receptor gamma, FTO fat mass and obesity-associated, CDKN2A/2B 
Cyclin dependent kinase inhibitor 2A/2B, KCNQ1 Potassium voltage-
gated channel subfamily Q member 1 and CAPN10 Calpain 10
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present in each individual. The GRS was generated from 
the following SNPs: rs12255372, rs7903146 of the Tran-
scription factor 7-like 2 (TCF7L2) gene, rs17782313 of the 
MC4R gene, rs8050136 and rs10163409 of the fat mass 
and obesity-associated (FTO), rs2237892 and rs2237895 
of the Potassium voltage-gated channel subfamily Q mem-
ber 1(KCNQ1) gene, rs10811661 of the Cyclin dependent 
kinase inhibitor 2A/2B (CDKN2A/2B) gene, rs5030952 of 
the CAPN10 gene, and rs1801282 of the Peroxisome pro-
liferator-activated receptor gamma (PPARG ) gene. Geno-
types were coded as 0, 1, or 2 according to the number of 
metabolic-associated risk alleles that are defined based 
on the literature. These values were then calculated by 
summing the number of risk alleles for each variant. The 
GRS was then categorised based on the median risk alleles 
into two categories: “GRS < 5 risk alleles” and “GRS ≥ 5 
risk alleles”.
Statistical analysis
Descriptive characteristics of the study population strati-
fied by sex were presented as means and standard deviation 
(SDs) for continuous variables and compared using an inde-
pendent samples t-test. Variables were tested for normality 
using Shapiro–Wilk's W test and non-normally distributed 
variables were log-transformed including BMI, WC, body 
fat mass percentage, HbA1c, fasting glucose, fasting insu-
lin, HOMA-IR, HOMA-B, insulin to glucose ratio, total 
energy intake (TEI), carbohydrate %, protein %, SFA %, and 
polyunsaturated fatty acids (PUFA) %. We investigated the 
effects of metabolic-GRS on metabolic traits using general 
linear models. To test the interactions of the metabolic-GRS 
with dietary factors on metabolic traits, we included the 
interaction term (e.g., GRS*fat intake) in the models. The 
dietary factors investigated in our study included the total 
dietary intake of fat, protein, and carbohydrate (percentages 
of TEI). Significant interactions between the GRS and the 
total fat intake were analysed in more depth to determine the 
effect of fat subtypes including SFA, monounsaturated fatty 
acids (MUFA), and PUFA. The GRS-nutrient interactions 
that reached statistical significance (p < 0.05) were tested for 
the effects of the GRSs on metabolic traits according to ter-
tiles of dietary intakes (low, medium and high intake) using 
general linear models. All models were adjusted for age, sex 
and BMI (when BMI is not an outcome). Given that insulin 
levels are influenced by both the capacity for insulin secre-
tion and IR [46, 47], analysis of HOMA-B was performed 
with and without adjustment for IR to improve the accuracy 
of pancreatic β‐cell function estimate. All statistical tests 
were two-sided, and analyses were performed using Statisti-
cal Package for the Social Sciences (SPSS) software (version 
24; SPSS Inc., Chicago, IL, USA).
Results
Characteristics of the study participants
Table 1 summarises the characteristics of individuals in this 
study according to sex. Men had higher BMI, WC, fasting 
glucose, and lower fat mass % compared to women (P < 0.05 
for all). Men also reported higher intakes of total energy and 
protein than women (P < 0.05 for all).
Associations between metabolic‑GRS and metabolic 
traits
None of the associations between metabolic-GRS and meta-
bolic-disease related traits was statistically significant except 
for the association with BMI (P = 0.008) (Table 2). 
Interactions of metabolic‑GRS with dietary factors 
on metabolic traits
As shown in Table 3, there were statistically significant 
interactions between the metabolic-GRS and total fat intake 
(% of TEI) on fasting insulin level  (Pinteraction = 0.017), 
insulin-glucose ratio  (Pinteraction = 0.010) and HOMA-B 
 (Pinteraction = 0.002) and a borderline interaction on HOMA-
IR  (Pinteraction = 0.051). Among those in the highest tertile 
of fat intake (37.98 ± 3.39% of TEI), individuals with ≥ 5 
risk alleles had higher fasting insulin level (P = 0.021), 
insulin-glucose ratio (P = 0.010), HOMA-B (P = 0.001) 
and HOMA-IR (P = 0.053), compared to those with < 5 
risk alleles (Figs. 2 and 3). Interaction on HOMA-B was 
still significant after adjusting the analysis for HOMA-
IR  (Pinteraction = 0.016), Figure S1. We further examined 
interactions with fat subtypes on these traits. Significant 
interactions were detected between the metabolic-GRS 
and MUFA intake on fasting insulin  (Pinteraction = 0.021), 
HOMA-IR  (Pinteraction = 0.021) and insulin to glucose ratio 
 (Pinteraction = 0.031), however, none of these interactions was 
statistically significant after tertile analysis. Significant inter-
actions were also observed between the metabolic-GRS and 
intakes of total fat, PUFA and MUFA on percentage of body 
fat mass  (Pinteraction = 0.009, 0.033 and 0.038, respectively).
Discussion
The present study investigated the potential interplay 
between metabolic-GRS and dietary macronutrient intake 
on metabolic traits in a Brazilian young adult population. 
Our results provide evidence of significant GRS-fat intake 
interactions on glucose and insulin-related traits, where 
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individuals with ≥ 5 risk alleles had higher fasting insulin 
level, insulin-glucose ratio, HOMA-IR and HOMA-B than 
those with < 5 risk alleles among those in the high fat intake 
group (37.98 ± 3.39% of TEI). These findings suggest that 
individuals with ≥ 5 risk alleles are sensitive to dietary fat 
with respect to glucose and insulin-related traits and that 
these individuals may derive the most benefit from following 
the Brazilian dietary guidelines which aim at reducing fat 
intake to less than 30% of TEI [48]. This could have signifi-
cant implication for public health in terms of providing early 
intervention to young adults with high genetic risk before 
the onset of disease, which might help halt the development 
of T2D.
In the present study, the metabolic-GRS was found to be 
associated with lower BMI, which contradicts the findings 
of the previous GRS-related studies in European popula-
tions [49–52]. However, the Brazilian population has a 
mixed genetic ancestry that originates from Europeans, 
Africans and Native Amerindians, which might explain the 
discrepancies between our findings and genetic association 
Table 1  Characteristics of study 
participants
Data presented as the mean ± SDs. P values for the differences in the means between men and women were 
calculated using the independent samples t-test. BMI body mass index, WC waist circumference, HbA1c 
glycated haemoglobin, HOMA-IR homeostasis model assessment estimate of insulin resistance, HOMA-B 
homeostasis model assessment estimate of insulin secretion, SFA saturated fatty acids, MUFA monounsatu-
rated fatty acids, PUFA polyunsaturated fatty acids
Parameters Total (n = 200) Women (n = 147) Men (n = 53) p‐Value
Age (years) 21.35 ± 1.67 21.33 ± 1.70 21.40 ± 1.61 0.815
BMI (kg/m2) 23.35 ± 4.42 22.81 ± 3.97 24.86 ± 5.23 0.004
WC (cm) 74.55 ± 13.56 71.10 ± 12.05 84.13 ± 13.01 0.000
Body fat mass (%) 33.91 ± 10.72 37.17 ± 8.77 24.84 ± 10.48 0.000
HbA1c (%) 4.73 ± 0.25 4.71 ± 0.25 4.78 ± 0.26 0.103
Fasting serum glucose (mg/dL) 87.18 ± 6.84 86.43 ± 6.78 89.26 ± 6.60 0.009
Fasting serum insulin (uU/mL) 8.74 ± 3.80 8.69 ± 3.37 8.88 ± 4.82 0.784
HOMA-IR 1.89 ± 0.88 1.86 ± 0.76 1.98 ± 1.15 0.513
HOMA-B 138.32 ± 65.75 142.47 ± 65.65 126.81 ± 65.25 0.137
Insulin to glucose ratio 0.10 ± 0.04 0.10 ± 0.04 0.10 ± 0.05 0.944
Energy (Kcal/day) 1827.81 ± 597.94 1741.52 ± 558.82 2067.15 ± 641.91 0.001
Protein (energy %) 17.11 ± 3.63 16.74 ± 3.33 18.14 ± 4.24 0.016
Carbohydrate (energy %) 51.09 ± 7.11 51.11 ± 7.01 51.05 ± 7.44 0.961
Fat (energy %) 31.66 ± 5.83 32.12 ± 5.69 30.38 ± 6.08 0.061
SFA (%) 9.43 ± 5.43 9.54 ± 6.030 9.14 ± 3.25 0.652
PUFA (%) 5.13 ± 2.27 5.08 ± 2.38 5.26 ± 1.92 0.628
MUFA (%) 7.72 ± 2.63 7.55 ± 2.55 8.19 ± 2.79 0.129
Table 2  Associations of 
metabolic-GRS with metabolic 
traits
Data are Mean ± standard error of the mean (SEM). P values obtained from the linear regression analysis 
adjusted for age, sex and additionally for BMI when BMI is not an outcome. The analysis was performed 
on log-transformed variables. GRS genetic risk score, BMI body mass index, WC waist circumference, 
HbAIc glycated haemoglobin, HOMA-IR homeostasis model assessment estimate of insulin resistance, 
HOMA-B homeostasis model assessment estimate of insulin secretion
Parameters GRS < 5 (n = 93) GRS ≥ 5 (n = 101) p‐Value
BMI (kg/m2) 23.90 ± 0.43 22.60 ± 0.43 0.008
WC (cm) 75.53 ± 1.27 73.93 ± 1.26 0.967
Body fat mass (%) 35.80 ± 1.05 31.91 ± 1.10 0.663
HbA1c (%) 4.72 ± 0.03 4.73 ± 0.03 0.964
Fasting glucose (mg/dL) 87.54 ± 0.68 86.74 ± 0.72 0.419
Fasting insulin (uU/mL) 8.91 ± 0.43 8.52 ± 0.34 0.542
HOMA-IR 1.93 ± 0.10 1.84 ± 0.08 0.663
HOMA-B 138.76 ± 7.15 138.17 ± 6.32 0.234
HOMA-B adjusted for HOMA-IR 138.76 ± 7.15 138.17 ± 6.32 0.235
Insulin to glucose ratio 0.10 ± 0.00 0.10 ± 0.00 0.477
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studies in Europeans [53]. Furthermore, a large GWAS of 
241,258 European adults showed that the risk allele T of 
TCF7L2 rs7903146 was associated with lower BMI com-
pared to the non-risk allele, which may provide a possible 
explanation of our findings [54]. Metabolic diseases are 
complex and multifactorial influenced by both environ-
mental and genetic factors including dozens or even hun-
dreds of genetic variants each contributing small effects on 
these traits [55, 56]. Thus, the effect of unmeasured factors 
on BMI might influence the observed findings.
The present study found that, within the high-fat intake 
category, individuals with higher metabolic-GRS showed 
increased fasting insulin level, insulin-glucose ratio, 
HOMA-IR and HOMA-B, whereas those with lower GRS 
showed a reduction in these traits. Although direct com-
parison of our study with previous gene-diet interaction 
studies is difficult due to differences in the methodology 
related to the construction of GRSs and measurement of 
dietary intake, sample size, study design, and ethnicity, 
our findings are in agreement with some of the previous 
studies in other populations in which fat intake was found 
to interact with GRS on metabolic traits [33–35]. In a 
recent study in 302 Ghanaian adults, a GRS of 4 met-
abolic-related variants was associated with higher WC 
among individuals with high fat intake (34.99 ± 5.54% 
TEI) [57]. Data from an intervention study in 733 Euro-
pean adults also reported that higher total fat intake was 
associated with increased fasting glucose in individuals 
with higher GRS of 14 fasting glucose-associated SNPs 
and with decreased fasting glucose among individuals with 
lower GRS [33]. Taken together, these observations sug-
gest that individuals with higher genetic risk might benefit 
more from reducing fat intake in terms of lowering their 
metabolic risk.
Dietary guidelines have recommended to limit the dietary 
intake of total fat (between 15 and 30% of TEI) to preserve 
overall health and reduce the risk of developing metabolic 
diseases [58]. Previous studies have demonstrated that the 
higher intake of total fat contributes to the development of 
T2D by inducing IR [24, 59]. Lowering total fat intake have 
been reported to improve glycemic control in a systematic 
review of clinical trials of diabetic individuals [60]. Evi-
dence from two previous intervention studies including 
individuals from various ethnic groups (n = 3,234 and 522, 
respectively) and with long follow-up (2.8 and 3.2 years, 
respectively) have also shown that decreasing fat intake 
(from 6.6 ± 0.2% of TEI and to < 30% of TEI, respectively) 
is effective in reducing the incidence of T2D by up to 58% 
[61, 62]. In addition, dietary intervention in 48,835 post-
menopausal women from the US showed that reducing total 
fat intake (by ~ 8% of TEI) and increasing carbohydrate 
intake (by ~ 8% of TEI) through increasing intake of veg-
etable/fruit (five servings per day) and grain (six servings 
per day) were associated with a reduction in glycemia and 
diabetes progression [63]. The dietary intake of Brazilians 
is characterised by unfavourable fat profile with high intakes 
of SFA and trans fatty acids and imbalances in the omega-
6:omega-3 ratio, being compatible with a high risk of meta-
bolic diseases [21]. In our study, the mean fat intake of the 
total sample (31.66 ± 5.8% of TEI) and the high fat intake 
group (37.98 ± 3.39% of TEI) were above the recommended 
dietary guidelines for Brazilian adults (< 30% of TEI) [64].
The mechanisms by which dietary fat influences IR and 
β-cell function are unclear; however, several pathways are 
Table 3  Interactions of the 
metabolic-GRS with dietary 
factors on metabolic traits
Data are P values of interaction which obtained from the linear regression analysis adjusted for age, sex 
and additionally for BMI when BMI is not an outcome. The analysis was performed on log-transformed 
variables. GRS genetic risk score, BMI body mass index, WC waist circumference, HbA1c glycated hae-
moglobin, HOMA-IR homeostasis model assessment estimate of insulin resistance, HOMA-B homeostasis 
model assessment estimate of insulin secretion, SFA saturated fatty acids, MUFA monounsaturated fatty 
acids, PUFA polyunsaturated fatty acids






BMI (kg/m2) 0.255 0.120 0.922 - - -
WC (cm) 0.124 0.303 0.979 - - -
Body fat mass (%) 0.451 0.311 0.009 0.255 0.033 0.038
HbA1c (%) 0.955 0.653 0.632 - - -
Fasting glucose (mg/dL) 0.764 0.142 0.099 - - -
Fasting insulin (uU/mL) 0.898 0.37 0.017 0.233 0.809 0.021
HOMA-IR 0.944 0.561 0.051 0.357 0.837 0.021
HOMA-B 0.797 0.089 0.002 0.079 0.749 0.123
HOMA-B adjusted for HOMA-IR 0.784 0.084 0.016 0.131 0.806 0.952
Insulin to glucose ratio 0.895 0.274 0.010 0.154 0.801 0.031
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biologically plausible. IR is often mediated by increased 
inflammation that has been shown to be induced mostly by 
the effect of the fatty acids composition of the diet [65]. In 
particular, SFA and omega-6 have pro-inflammatory effects, 
and omega-3 fatty acids have anti-inflammatory effects [65]. 
Some of the molecular mechanisms of IR include the lipid-
overload hypothesis in which ceramides or diacylglycerides 
are accumulated leading to the inhibition of insulin signal-
ling and oxidative stress induced by excessive generation 
of free radicals or endoplasmic reticulum stress induced by 
excessive calorie intake [66–68]. In addition to the insulin-
related traits, there was also a significant interaction between 
GRS and intakes of total fat, PUFA and MUFA on the per-
centage of body fat mass in our study. Given that adipose tis-
sue is a central metabolic organ that stores excess fat energy 
in the form of lipid and secretes proinflammatory adipokines 
that can also influence signalling of insulin, our finding is 
biologically plausible [69]. It is worth observing the intake 
of SFA, PUFA and MUFA which were significantly higher 
in the high fat intake category than low and medium intake 
groups; this might be one of the reasons for the observed 
interactions with total dietary fat intake. Evidence suggests 
that different types of dietary fat have differential effects 
on IR and insulin secretion. While a cross-sectional study 
in 538 Spanish individuals suggested that the intake of a 
MUFA-rich diet was associated with increased HOMA-B 
[70], a meta-analysis of randomised controlled feeding tri-
als (n = 4220) demonstrated that PUFA intake showed the 
most consistent favourable effects in relation to improved 
glycaemia and insulin secretion capacity [71].
Several strengths are worth consideration. This study is 
the first to examine whether dietary factors interact with 
metabolic-GRSs on metabolic traits among the Brazilian 
Fig. 2  Interaction between the metabolic-GRS and fat intake (%) on 
fasting insulin levels and insulin: glucose ratio. White bars indicate 
individuals with GRS < 5 risk alleles; the black bars indicate indi-
viduals with GRS ≥ 5 risk alleles; Error bars indicate the standard 
error of the mean. Individuals with ≥ 5 risk alleles had higher fast-
ing insulin (a) and insulin to glucose ratio (b) compared to those 
with < 5 risk alleles, among individuals with a higher total fat intake 
(37.98 ± 3.39% of TEI). GRS genetic risk score, TEI total energy 
intake
Fig. 3  Interaction between the metabolic-GRS and fat intake (%) 
on HOMA-IR and HOMA-B. White bars indicate individuals with 
GRS < 5 risk alleles; the black bars indicate individuals with GRS ≥ 5 
risk alleles; Error bars indicate the standard error of the mean. Indi-
viduals with ≥ 5 risk alleles had higher HOMA-IR (a) and HOMA-B 
(b) compared to those with < 5 risk alleles, among individuals with a 
higher total fat intake (37.98 ± 3.39% of TEI). GRS genetic risk score, 
TEI total energy intake, HOMA‐IR homeostasis model assessment 
estimate of insulin resistance, HOMA‐B homeostasis model assess-
ment estimate of insulin secretion
 Journal of Diabetes & Metabolic Disorders
1 3
young adult population. Early prediction of insulin sensi-
tivity in young adults and effective intervention can be a 
critical factor in terms of delaying or preventing diabetes 
in normoglycemic individuals who are at risk of diabetes 
[72]. Also, a GRS analysis approach was used, which has the 
advantage over single-locus approach [32]. This approach 
is especially important for highly polygenic metabolic traits 
and can identify individuals at risk of metabolic diseases 
who might benefit from targeted interventions [32]. Further-
more, the study outcomes (metabolic traits) were measured 
using validated methods by trained staff which improve the 
accuracy of these estimates. Nevertheless, some limita-
tions need to be acknowledged. A major limitation is the 
small sample size, suggesting that our analysis might be 
underpowered. However, the use of the GRS approach is 
suggested to improve the power and significant gene-diet 
interactions were detected in our study. As with all obser-
vational studies, causality between exposure and outcome 
cannot be inferred and residual confounders might have 
existed. Given the longitudinal dimension of the develop-
ment of T2D and the complexity of gene-diet interactions, 
our cross-sectional study design fails to determine the tem-
porality of the observed findings. Given that dietary intake 
was assessed using self-reported measures, we cannot 
exclude the effect of measurement bias. Another limitation 
is that the effect of different dietary sources of fat (including 
meat, dairy and plant) were not considered in the present 
analysis, which might have provided further explanations to 
our GRS-fat intake interactions [73]. In addition, our GRS 
was constructed based on 10 SNPs, which account for only 
a small proportion of the metabolic disease-related genetic 
variants. As HOMA is a widely validated clinical and epi-
demiological tool for assessing IR and β-cell function [74], 
like many other epidemiological studies [33, 35, 59], we 
also used HOMA-IR and HOMA-B as proxies for IR and 
insulin secretion, respectively. However, these measures 
are calculated only using fasting insulin and glucose values 
which might provide different estimates compared to meth-
ods based on dynamic measurements of insulin and glucose 
responses or those derived from clamp experiments [75]. 
Finally, given that the study was performed with relatively 
healthy overweight/obese young individuals with normal 
glucose tolerance who might have a quicker adaptation to 
changes in fat intake, the findings might not be applicable to 
those with impaired glucose metabolism or diabetes.
In conclusion, our study provides evidence of interac-
tions between genetic predisposition and high fat intake 
on diabetes-related traits among Brazilian young adults. 
These findings encourage identifying Brazilian young 
adults with high genetic risk and tailoring dietary rec-
ommendations of fat intake according to their metabolic 
genetic risk profile for the primary prevention of adult-
onset T2D. In addition, devising polygenic risk score 
could be used to provide more insights on understanding 
the pathophysiology of the genetics of diabetes. However, 
large interventional and follow up studies with a more 
comprehensive and objective assessment of environmen-
tal factors are needed in Brazilians to confirm our find-
ings and to evaluate the clinical benefit of implementing 
precision dietary interventions based on an individual’s 
underlying genetic risk of metabolic diseases.
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